News

Biomednewsbreaks - Nanoviricides (NYSE American: NNVC) Reports Breakthrough Measles Drug Success In Humanized Animal Study
NanoViricides, Inc. (NYSE American: NNVC) , a clinical-stage developer of broad-spectrum antivirals using host-mimetic nanomedicine, announced promis ...
Royal LePage Terrequity Realty Wins 2025 Consumer Choice Award for Residential Real Estate in Toronto Central
TORONTO, ONTARIO / ACCESS Newswire / July 21, 2025 / Royal LePage Terrequity Realty has been honoured with the 2025 Consumer Choice Award in the Residential Real Estate category for Toronto Central, ...
Measles Now Has a Drug – NV-387 Broad-Spectrum Antiviral Successful in Animal Studies, says NanoViricides
SHELTON, CT / ACCESS Newswire / July 21, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.: NNVC ) (the ...